Methods |
|
|
Participants |
|
|
Interventions | Machine perfusion
Static cold storage
Mean CIT
|
|
Outcomes |
|
|
Notes |
|
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | High risk | There was no information on how kidneys were randomised. Furthermore, surgeons could swap kidneys from the HMP to the SCS if they felt the aortic patch was too small or if the anatomy of the renal arteries was non‐standard. No intention to treat analysis was applied. No indication was given as to how many kidneys were swapped between groups |
Allocation concealment (selection bias) | High risk | Allocation concealment was not possible with the study design, kidneys were moved between groups without intention to treat analysis |
Blinding of participants and personnel (performance bias) All outcomes | High risk | No blinding and no reporting of CIT. Therefore one group may have routinely been transplanted first, adding bias to the results |
Blinding of outcome assessment (detection bias) All outcomes | High risk | No blinding of DGF data. No information is given as to whether the assessors of "acute rejection" or "time zero biopsies" were blinded |
Incomplete outcome data (attrition bias) All outcomes | High risk | For the outcome "time‐zero biopsies" no data is given for the groups as a whole. Only H+E stains and electron microscopy from a single pair of kidneys are presented |
Selective reporting (reporting bias) | High risk | A non‐standard definition for DGF was used as the primary outcome of the study. The number of participants requiring dialysis in the first week post‐transplant (the standard definition for DGF) was not reported. No specific outcome was associated with the "time‐zero biopsies". In the results section some features of H+E stains, and electron microscopy were reported, leaving a high risk of selection bias. Furthermore, only H+E stains and electron microscopy from a single pair of kidneys are presented |
Other bias | High risk | Although acute rejection is reported as an outcome, it is not stated whether this is biopsy proven rejection or clinical rejection. It is also not stated over what time period acute rejection data was collected over |